Stage-Specific Secretion of HMGB1 in Cartilage Regulates Endochondral Ossification

REFERENCES

• Abeyama, K., D. M. Stern, Y. Ito, K. Kawahara, Y. Yoshimoto, M. Tanaka, T. Uchimura, N. Ida, Y. Yamazaki, S. Yamada, Y. Yamamoto, H. Yamamoto, S. Iino, N. Taniguchi, and I. Maruyama. 2005. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J. Clin. Investig. 115:1267–1274.
   PubMed Web of Science ®Google Scholar
• Agresti, A., and M. E. Bianchi. 2003. HMGB proteins and gene expression. Curr. Opin. Genet. Dev. 13:170–178.
   PubMed Web of Science ®Google Scholar
• Albrecht, U., G. Eichele, J. A. Helms, and H. Lu. 1997. Molecular and cellular methods in developmental toxicology. CRC Press, Boca Raton, FL.
   Google Scholar
• Andersson, U., H. Wang, K. Palmblad, A. C. Aveberger, O. Bloom, H. Erlandsson-Harris, A. Janson, R. Kokkola, M. Zhang, H. Yang, and K. J. Tracey. 2000. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192:565–570.
   PubMed Web of Science ®Google Scholar
• Ballock, R. T., and A. H. Reddi. 1994. Thyroxine is the serum factor that regulates morphogenesis of columnar cartilage from isolated chondrocytes in chemically defined medium. J. Cell Biol. 126:1311–1318.
   PubMed Web of Science ®Google Scholar
• Binette, F., D. P. McQuaid, D. R. Haudenschild, P. C. Yaeger, J. M. McPherson, and R. Tubo. 1998. Expression of a stable articular cartilage phenotype without evidence of hypertrophy by adult human articular chondrocytes in vitro. J. Orthop. Res. 16:207–216.
   PubMed Web of Science ®Google Scholar
• Blavier, L., and J. M. Delaisse. 1995. Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. J. Cell Sci. 108(Pt. 12):3649–3659.
   PubMedGoogle Scholar
• Bonaldi, T., F. Talamo, P. Scaffidi, D. Ferrera, A. Porto, A. Bachi, A. Rubartelli, A. Agresti, and M. E. Bianchi. 2003. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it toward secretion. EMBO J. 22:5551–5560.
   PubMed Web of Science ®Google Scholar
• Brett, J., A. M. Schmidt, S. D. Yan, Y. S. Zou, E. Weidman, D. Pinsky, R. Nowygrod, M. Neeper, C. Przysiecki, A. Shaw, et al. 1993. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am. J. Pathol. 143:1699–1712.
   PubMed Web of Science ®Google Scholar
• Bustin, M. 1999. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol. Cell. Biol. 19:5237–5246.
   PubMed Web of Science ®Google Scholar
• Calogero, S., F. Grassi, A. Aguzzi, T. Voigtlander, P. Ferrier, S. Ferrari, and M. E. Bianchi. 1999. The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat. Genet. 22:276–280.
   PubMed Web of Science ®Google Scholar
• Charoonpatrapong, K., R. Shah, A. G. Robling, M. Alvarez, D. W. Clapp, S. Chen, R. P. Kopp, F. M. Pavalko, J. Yu, and J. P. Bidwell. 2006. HMGB1 expression and release by bone cells. J. Cell Physiol. 207:480–490.
   PubMed Web of Science ®Google Scholar
• Degryse, B., T. Bonaldi, P. Scaffidi, S. Muller, M. Resnati, F. Sanvito, G. Arrigoni, and M. E. Bianchi. 2001. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J. Cell Biol. 152:1197–1206.
   PubMed Web of Science ®Google Scholar
• Dumitriu, I. E., P. Baruah, B. Valentinis, R. E. Voll, M. Herrmann, P. P. Nawroth, B. Arnold, M. E. Bianchi, A. A. Manfredi, and P. Rovere-Querini. 2005. Release of high mobility group box 1 by dendritic cells controls T-cell activation via the receptor for advanced glycation end products. J. Immunol. 174:7506–7515.
   PubMed Web of Science ®Google Scholar
• Engsig, M. T., Q. J. Chen, T. H. Vu, A. C. Pedersen, B. Therkidsen, L. R. Lund, K. Henriksen, T. Lenhard, N. T. Foged, Z. Werb, and J. M. Delaisse. 2000. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J. Cell Biol. 151:879–889.
   PubMed Web of Science ®Google Scholar
• Fukuyama, R., T. Fujita, Y. Azuma, A. Hirano, H. Nakamuta, M. Koida, and T. Komori. 2004. Statins inhibit osteoblast migration by inhibiting Rac-Akt signaling. Biochem. Biophys. Res. Commun. 315:636–642.
   PubMedGoogle Scholar
• Gerber, H. P., T. H. Vu, A. M. Ryan, J. Kowalski, Z. Werb, and N. Ferrara. 1999. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5:623–628.
   PubMed Web of Science ®Google Scholar
• Gerstenfeld, L. C., S. D. Chipman, J. Glowacki, and J. B. Lian. 1987. Expression of differentiated function by mineralizing cultures of chicken osteoblasts. Dev. Biol. 122:49–60.
   PubMed Web of Science ®Google Scholar
• Guazzi, S., A. Strangio, A. T. Franzi, and M. E. Bianchi. 2003. HMGB1, an architectural chromatin protein and extracellular signalling factor, has a spatially and temporally restricted expression pattern in mouse brain. Gene Expr. Patterns 3:29–33.
   PubMed Web of Science ®Google Scholar
• Haaijman, A., R. N. D'Souza, A. L. Bronckers, S. W. Goei, and E. H. Burger. 1997. OP-1 (BMP-7) affects mRNA expression of type I, II, X collagen, and matrix Gla protein in ossifying long bones in vitro. J. Bone Miner. Res. 12:1815–1823.
   PubMed Web of Science ®Google Scholar
• Hashimoto, S., R. L. Ochs, F. Rosen, J. Quach, G. McCabe, J. Solan, J. E. Seegmiller, R. Terkeltaub, and M. Lotz. 1998. Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc. Natl. Acad. Sci. USA 95:3094–3099.
   PubMed Web of Science ®Google Scholar
• Henriksen, K., M. Karsdal, J. M. Delaisse, and M. T. Engsig. 2003. RANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1/2-dependent mechanism. J. Biol. Chem. 278:48745–48753.
   PubMed Web of Science ®Google Scholar
• Holmbeck, K., P. Bianco, J. Caterina, S. Yamada, M. Kromer, S. A. Kuznetsov, M. Mankani, P. G. Robey, A. R. Poole, I. Pidoux, J. M. Ward, and H. Birkedal-Hansen. 1999. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99:81–92.
   PubMed Web of Science ®Google Scholar
• Imai, S., M. Kaksonen, E. Raulo, T. Kinnunen, C. Fages, X. Meng, M. Lakso, and H. Rauvala. 1998. Osteoblast recruitment and bone formation enhanced by cell matrix-associated heparin-binding growth-associated molecule (HB-GAM). J. Cell Biol. 143:1113–1128.
   PubMed Web of Science ®Google Scholar
• Inada, M., Y. Wang, M. H. Byrne, M. U. Rahman, C. Miyaura, C. Lopez-Otin, and S. M. Krane. 2004. Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc. Natl. Acad. Sci. USA 101:17192–17197.
   PubMed Web of Science ®Google Scholar
• Kikuchi, T., T. Matsuguchi, N. Tsuboi, A. Mitani, S. Tanaka, M. Matsuoka, G. Yamamoto, T. Hishikawa, T. Noguchi, and Y. Yoshikai. 2001. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J. Immunol. 166:3574–3579.
   PubMedGoogle Scholar
• Komori, T., H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki, K. Deguchi, Y. Shimizu, R. T. Bronson, Y. H. Gao, M. Inada, M. Sato, R. Okamoto, Y. Kitamura, S. Yoshiki, and T. Kishimoto. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755–764.
   PubMed Web of Science ®Google Scholar
• Lefebvre, V., S. Garofalo, G. Zhou, M. Metsaranta, E. Vuorio, and B. De Crombrugghe. 1994. Characterization of primary cultures of chondrocytes from type II collagen/beta-galactosidase transgenic mice. Matrix Biol. 14:329–335.
   PubMedGoogle Scholar
• Lian, J. B., G. S. Stein, C. Stewart, E. Puchacz, S. Mackowiak, M. Aronow, M. Von Deck, and V. Shalhoub. 1989. Osteocalcin: characterization and regulated expression of the rat gene. Connect. Tissue Res. 21:61–69.
   PubMed Web of Science ®Google Scholar
• Liu, W., S. Toyosawa, T. Furuichi, N. Kanatani, C. Yoshida, Y. Liu, M. Himeno, S. Narai, A. Yamaguchi, and T. Komori. 2001. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J. Cell Biol. 155:157–166.
   PubMed Web of Science ®Google Scholar
• McLeod, M. J. 1980. Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology 22:299–301.
   PubMedGoogle Scholar
• Mitola, S., M. Belleri, C. Urbinati, D. Coltrini, B. Sparatore, M. Pedrazzi, E. Melloni, and M. Presta. 2006. Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J. Immunol. 176:12–15.
   PubMed Web of Science ®Google Scholar
• Nakashima, K., and B. de Crombrugghe. 2003. Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet. 19:458–466.
   PubMed Web of Science ®Google Scholar
• Nakashima, K., X. Zhou, G. Kunkel, Z. Zhang, J. M. Deng, R. R. Behringer, and B. de Crombrugghe. 2002. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17–29.
   PubMed Web of Science ®Google Scholar
• Nomura, S., A. J. Wills, D. R. Edwards, J. K. Heath, and B. L. Hogan. 1988. Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J. Cell Biol. 106:441–450.
   PubMed Web of Science ®Google Scholar
• Okubo, Y., and A. H. Reddi. 2003. Thyroxine downregulates Sox9 and promotes chondrocyte hypertrophy. Biochem. Biophys. Res. Commun. 306:186–190.
   PubMed Web of Science ®Google Scholar
• Ortega, N., D. J. Behonick, and Z. Werb. 2004. Matrix remodeling during endochondral ossification. Trends Cell Biol. 14:86–93.
   PubMed Web of Science ®Google Scholar
• Palumbo, R., M. Sampaolesi, F. De Marchis, R. Tonlorenzi, S. Colombetti, A. Mondino, G. Cossu, and M. E. Bianchi. 2004. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J. Cell Biol. 164:441–449.
   PubMed Web of Science ®Google Scholar
• Park, J. S., D. Svetkauskaite, Q. He, J. Y. Kim, D. Strassheim, A. Ishizaka, and E. Abraham. 2004. Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279:7370–7377.
   PubMed Web of Science ®Google Scholar
• Park, K., B. H. Min, D. K. Han, and K. Hasty. 2007. Quantitative analysis of temporal and spatial variations of chondrocyte behavior in engineered cartilage during long-term culture. Ann. Biomed. Eng. 35:419–428.
   PubMedGoogle Scholar
• Passalacqua, M., M. Patrone, G. B. Picotti, M. Del Rio, B. Sparatore, E. Melloni, and S. Pontremoli. 1998. Stimulated astrocytes release high-mobility group 1 protein, an inducer of LAN-5 neuroblastoma cell differentiation. Neuroscience 82:1021–1028.
   PubMed Web of Science ®Google Scholar
• Sakiyama, H., T. Nonaka, R. Masuda, N. Inoue, Y. Kuboki, M. Iijima, Y. Hirabayasi, M. Takahagi, K. Yoshida, K. Kuriiwa, M. Yoshida, and S. Imajoh-Ohmi. 2002. Characterization of mineral deposits formed in cultures of a hamster tartrate-resistant acid phosphatase (TRAP) and alkaline phosphatase (ALP) double-positive cell line (CCP). Cell Tissue Res. 309:269–279.
   PubMedGoogle Scholar
• Salmivirta, M., H. Rauvala, K. Elenius, and M. Jalkanen. 1992. Neurite growth-promoting protein (amphoterin, p30) binds syndecan. Exp. Cell Res. 200:444–451.
   PubMed Web of Science ®Google Scholar
• Sato, T., M. del Carmen Ovejero, P. Hou, A. M. Heegaard, M. Kumegawa, N. T. Foged, and J. M. Delaisse. 1997. Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts. J. Cell Sci. 110(Pt. 5):589–596.
   PubMedGoogle Scholar
• Scaffidi, P., T. Misteli, and M. E. Bianchi. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191–195.
   PubMed Web of Science ®Google Scholar
• Schlueter, C., H. Weber, B. Meyer, P. Rogalla, K. Roser, S. Hauke, and J. Bullerdiek. 2005. Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. Am. J. Pathol. 166:1259–1263.
   PubMed Web of Science ®Google Scholar
• Stickens, D., D. J. Behonick, N. Ortega, B. Heyer, B. Hartenstein, Y. Yu, A. J. Fosang, M. Schorpp-Kistner, P. Angel, and Z. Werb. 2004. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 131:5883–5895.
   PubMed Web of Science ®Google Scholar
• Taguchi, A., D. C. Blood, G. del Toro, A. Canet, D. C. Lee, W. Qu, N. Tanji, Y. Lu, E. Lalla, C. Fu, M. A. Hofmann, T. Kislinger, M. Ingram, A. Lu, H. Tanaka, O. Hori, S. Ogawa, D. M. Stern, and A. M. Schmidt. 2000. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405:354–360.
   PubMed Web of Science ®Google Scholar
• Takami, M., N. Kim, J. Rho, and Y. Choi. 2002. Stimulation by Toll-like receptors inhibits osteoclast differentiation. J. Immunol. 169:1516–1523.
   PubMed Web of Science ®Google Scholar
• Talreja, J., M. H. Kabir, B. F. M., D. J. Stechschulte, and K. N. Dileepan. 2004. Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to gram-positive and gram-negative bacterial cell wall components. Immunology 113:224–233.
   PubMedGoogle Scholar
• Taniguchi, N., K. Kawahara, K. Yone, T. Hashiguchi, M. Yamakuchi, M. Goto, K. Inoue, S. Yamada, K. Ijiri, S. Matsunaga, T. Nakajima, S. Komiya, and I. Maruyama. 2003. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum. 48:971–981.
   PubMed Web of Science ®Google Scholar
• Vortkamp, A., K. Lee, B. Lanske, G. V. Segre, H. M. Kronenberg, and C. J. Tabin. 1996. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273:613–622.
   PubMed Web of Science ®Google Scholar
• Vu, T. H., and Z. Werb. 2000. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev. 14:2123–2133.
   PubMed Web of Science ®Google Scholar
• Wang, H., O. Bloom, M. Zhang, J. M. Vishnubhakat, M. Ombrellino, J. Che, A. Frazier, H. Yang, S. Ivanova, L. Borovikova, K. R. Manogue, E. Faist, E. Abraham, J. Andersson, U. Andersson, P. E. Molina, N. N. Abumrad, A. Sama, and K. J. Tracey. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248–251.
   PubMed Web of Science ®Google Scholar
• Wang, H., H. Yang, and K. J. Tracey. 2004. Extracellular role of HMGB1 in inflammation and sepsis. J. Intern. Med. 255:320–331.
   PubMed Web of Science ®Google Scholar
• Wang, K., H. Yamamoto, J. R. Chin, Z. Werb, and T. H. Vu. 2004. Epidermal growth factor receptor-deficient mice have delayed primary endochondral ossification because of defective osteoclast recruitment. J. Biol. Chem. 279:53848–53856.
   PubMed Web of Science ®Google Scholar
• Yamada, S., K. Inoue, K. Yakabe, H. Imaizumi, and I. Maruyama. 2003. High mobility group protein 1 (HMGB1) quantified by ELISA with a monoclonal antibody that does not cross-react with HMGB2. Clin. Chem. 49:1535–1537.
   PubMed Web of Science ®Google Scholar
• Youn, J. H., and J. S. Shin. 2006. Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J. Immunol. 177:7889–7897.
   PubMed Web of Science ®Google Scholar
• Zelzer, E., W. McLean, Y. S. Ng, N. Fukai, A. M. Reginato, S. Lovejoy, P. A. D'Amore, and B. R. Olsen. 2002. Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 129:1893–1904.
   PubMed Web of Science ®Google Scholar
• Zhou, Z., D. Immel, C. X. Xi, A. Bierhaus, X. Feng, L. Mei, P. Nawroth, D. M. Stern, and W. C. Xiong. 2006. Regulation of osteoclast function and bone mass by RAGE. J. Exp. Med. 203:1067–1080.
   PubMed Web of Science ®Google Scholar